Skip to main content
. 2018 Feb 23;11(2):321. doi: 10.3390/ma11020321

Figure 3.

Figure 3

Schematic of nanoparticle-transcription factor decoys (TFD) mediated treatment of MRSA (A) administration of nanoparticle-TFD nanocomplexes to bacteria; (B) TFD release in cytoplasm and binding of transcription factor; (C) inhibition of transcription; (D) failure to produce critical proteins; (E) bacterial inhibition. “Reproduced with permission from [111] published by © Royal Society of Chemistry.” (2014).